Overview
M Filippi-Massimo practices in Milan, Italy. Filippi-Massimo is highly rated in 4 conditions, according to our data. Their top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Primary Lateral Sclerosis, Thalamotomy, and Thymectomy.
Their clinical research consists of co-authoring 194 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple Sclerosis (MS)Filippi-Massimo isDistinguished. Learn about Multiple Sclerosis (MS).
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisFilippi-Massimo isAdvanced. Learn about Primary Lateral Sclerosis.
- Relapsing Multiple Sclerosis (RMS)Filippi-Massimo isAdvanced. Learn about Relapsing Multiple Sclerosis (RMS).
- Experienced
- Absence SeizureFilippi-Massimo isExperienced. Learn about Absence Seizure.
- Alternating Hemiplegia of ChildhoodFilippi-Massimo isExperienced. Learn about Alternating Hemiplegia of Childhood.
- Alzheimer's DiseaseFilippi-Massimo isExperienced. Learn about Alzheimer's Disease.
- Anti-NMDA Receptor EncephalitisFilippi-Massimo isExperienced. Learn about Anti-NMDA Receptor Encephalitis.
- CACH SyndromeFilippi-Massimo isExperienced. Learn about CACH Syndrome.
- COVID-19Filippi-Massimo isExperienced. Learn about COVID-19.